| Product ID |
Product Name |
CAS# |
Purity |
| Y3116522 |
POLYSTYRENE-B-POLY(ETHYLENE-RAN-BUTYLENE )-B-POLYSTYRENE-G-MALEIC ANHYDRIDE |
124578-11-6 |
95% |
| Y1256455 |
1H-Indole-3-methanamine, 5,6-dichloro-N,N-dimethyl- |
121872-64-8 |
97% |
| D958630 |
Chloro[(tricyclohexylphosphine)-2-(2'-aminobiphenyl)]palladium(II) |
1353658-81-7 |
97% |
| Y1260870 |
PY1 , 3,5-di(pyren-1-yl)pyridine |
1246467-58-2 |
98% |
| Y3116542 |
Benzene, 1-ethynyl-2-fluoro-4-(trifluoroMethyl)- |
1233506-35-8 |
95% |
| Y3143082 |
3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-2-fluoropropanoic ac |
1268519-63-6 |
95% |
| Y3125128 |
3-methyl-5-nitropicolinicacid |
1211578-56-1 |
95% |
| Y3125161 |
BenzenaMine, 3-broMo-5-(1,1-diMethylethoxy)- |
1369896-27-4 |
95% |
| D770556 |
(difluoromethanesulfinyloxy)zincio difluoromethanesulfinate |
1355729-38-2 |
95% |
| Y3113260 |
Benzeneacetic acid, 2-[(4-chlorophenyl)thio]- |
13459-62-6 |
97% |
| D750010 |
(5-Methylbenzofuran-2-yl)boronic acid |
143381-72-0 |
98% |
| Y3314566 |
1-BroMo-N-phenylcarbazole |
1333002-37-1 |
97% |
| Y1337609 |
2-Hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile |
1350933-21-9 |
95% |
| Y3310005 |
3-Bromo-4-fluoro-5-nitrobenzamide |
1345471-86-4 |
98% |
| D760120 |
2-(3,5-Dibromo-2-pyridylazo)-5-(diethylamino)-phenol |
14337-54-3 |
97% |
| Y1235039 |
2-methyl-6-methyleneoct-7-en-4-ol |
14314-21-7 |
98% |
| Y1239304 |
TRANS (+/-) 1-[(TERT-BUTYL)OXYCARBONYL]-4-(2-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID |
1212102-71-0 |
95% |
| Y1239398 |
Dabigatran Impurity p |
1408238-37-8 |
98% |
| Y1239374 |
2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1415566-28-7 |
98% |
| Y3312940 |
2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1335202-59-9 |
98% |
| Y3311056 |
PF-03758309 (hydrochloride) |
1279034-84-2 |
98% |
| Y1235011 |
Pyrromethene 567 |
131083-16-4 |
98% |
| Y1239392 |
1-Bromo-3,5-dihexylbenzene |
1238156-36-9 |
96% |
| Y1235026 |
2-(2-Propynyloxy)ethylamine |
122116-12-5 |
98% |
| D758299 |
2,6-Di(1-pyrazolyl)pyridine |
123640-38-0 |
98% |
| Y3116516 |
3,6-Dibromo-9-(triphenylen-2-yl)carbazole |
1351870-16-0 |
98% |
| Y1239376 |
5,5'''-Dihexyl-2,2' |
132814-92-7 |
98% |
| Y1239335 |
6,6,7,7,8,8,8-Heptafluoro-5,5-bis(trifluoromethyl)-1,3-octadiene |
1429188-77-1 |
98% |
| D958644 |
Diethylene Glycol Bis(2-propynyl) Ether |
126422-57-9 |
98.0% |
| D759413 |
1 4-BIS(DIPHENYLAMINO)BENZENE |
14118-16-2 |
95+% |
| Y1235027 |
1-PhenylethylaMine HCl |
13437-79-1 |
95% |
| Y1235098 |
2-Methoxy-5-methylpyridin-3-ol |
1227574-65-3 |
tech grade |
| Y1239394 |
1-Pivaloyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]-oxazine-6-carboxylic acid |
1228665-93-7 |
95% |
| Y3312562 |
4-BroMo-2,5-difluoropyridine |
1349718-16-6 |
95% |
| Y1239305 |
3-[2-(2-Hydroxyethoxy)ethoxy]propanoic acid |
1334286-77-9 |
95% |
| Y1335085 |
1-BOC-2,3-Dihydropyrrole-4-boronic acid, pinacol ester |
1401165-14-7 |
98% |
| Y3110972 |
Methyl 2-chloro-4-(furan-2-yl)benzoate |
1414029-18-7 |
96% |
| Y1314567 |
Methyl 1-ethylbenzotriazole-5-carboxylate |
1393441-71-8 |
98% |
| Y1235046 |
3-Chloro-4-(cyclopropylMethoxy)phenylboronic acid |
1228181-35-8 |
98% |
| Y1343371 |
4-Chloro-1-methylindole-2-boronic acid, pinacol ester |
1256360-42-5 |
96% |
| Y1235047 |
3-Chloro-5-(pyrrolidin-1-yl)phenylboronic acid |
1402238-28-1 |
96% |
| Y1239306 |
(Z)-3-Fluoro-N'-hydroxybenzene-1-carboxiMidaMide |
1319746-46-7 |
95% |
| Y1238917 |
2-Cyano-5-(trifluoroMethyl)phenylboronic acid |
1375110-43-2 |
98% |
| Y3315930 |
3,4-DibroMophenylboronic acid |
1228180-83-3 |
97% |
| Y3143087 |
2,4-Dichloro-5-fluorophenylboronic acid |
1417914-09-0 |
95% |
| Y3112947 |
4,5-Difluoro-2-formylphenylboronic acid |
1432610-24-6 |
95% |
| Y3113183 |
6-Isobutoxynaphthalene-2-boronic acid |
1228310-17-5 |
95% |
| Y3113118 |
4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)morpholine |
1402172-49-9 |
98% |
| Y3112955 |
2-Piperidin-1-yl-thiazole-5-boronic acid pinacol ester |
1350755-62-2 |
98% |
| Y3147230 |
7-BroMo-1H-1,2,3-benzotriazole-5-carboxylic acid |
1354771-68-8 |
95% |
| Y3147241 |
1-BroMo-4-(chloroMethyl)-2-fluorobenzene |
1214322-98-1 |
95% |
| Y1239014 |
1-BroMo-4-(chloroMethyl)-2-(trifluoroMethyl)benzene |
1214339-27-1 |
95% |
| Y3117415 |
1-BroMo-2-ethoxy-4,5-difluorobenzene |
1266253-71-7 |
95% |
| Y1239020 |
4-BroMo-1-[3-(trifluoroMethyl)phenyl]pyrazole |
1353855-69-2 |
97% |
| Y3117547 |
4,6-DibroMo-2-fluoropyridin-3-ol |
1211597-14-6 |
98% |
| Y3135359 |
Ethyl 7-broMo-1H-1,3-benzodiazole-5-carboxylate |
1354771-56-4 |
95% |
| Y1238949 |
Methyl 7-broMo-1H-benzodiazole-5-carboxylate |
1354756-19-6 |
98% |
| Y3117747 |
2-(Benzyloxy)-4-broMobenzaldehyde |
142602-43-5 |
95% |
| Y3147687 |
5-[(t-Butoxy)carbonyl]pyridine-2-carboxylic acid |
1415819-86-1 |
95% |
| D963492 |
Methyl 5-(diMethoxyMethyl)pyridine-2-carboxylate |
125734-49-8 |
95% |
| Y3313832 |
3-AMino-5-broMo-4-fluorobenzoic acid |
1290117-11-1 |
97% |
| Y3147691 |
2-AMino-5-ethoxybenzaMide |
1250898-29-3 |
95% |
| Y1376913 |
tert-Butyl (2-(benzylaMino)ethyl)carbaMate hydrochloride |
126402-64-0 |
95% |
| Y1337652 |
4-(4-Benzyloxyphenyl)-3-fluorophenol |
1261982-07-3 |
96% |
| Y1239021 |
Benzyl N-[2-(4-fluorophenyl)propan-2-yl]carbaMate |
1403483-60-2 |
97% |
| Y1239101 |
Boc-(+/-)-trans-4-(4-pyridinyl)-pyrrolidine-3-carboxylic acid |
1255935-12-6 |
95% |
| D770558 |
3-(4-BroMopyrazol-1-yl)piperidine, HCl |
1375069-08-1 |
97% |
| Y1238979 |
3-Chloro-6-hydrazinylpicoline |
1388061-23-1 |
97% |
| Y3147479 |
Methyl 1-(2-fluorophenyl)-5-oxopyrrolidine-3-carboxylate |
1239772-19-0 |
95% |
| Y3147493 |
2-(Thiophen-3-yl)acetaMide |
13781-66-3 |
95% |
| Y1239349 |
[1-(4-Fluorophenyl)cyclobutyl]MethanaMine, HCl |
1228879-30-8 |
90% |
| Y1234981 |
4-Iodopiperidine, HCl |
1353979-67-5 |
97% |
| Y1235105 |
2-Methoxy-4-(piperidin-1-yl)aniline |
1340334-65-7 |
97% |
| Y3147267 |
Methyl 1-(4-Methoxyphenyl)-5-oxopyrrolidine-3-carboxylate |
133747-97-4 |
95% |
| Y3147270 |
Afatinib-d6 |
1313874-96-2 |
99% |
| Y1239302 |
Crizotinib-d5 |
1395950-84-1 |
99.2% D |
| Y1239383 |
Apixaban-13C-D3 |
1261393-15-0 |
99% |
| Y3292809 |
Moxifloxacin Decarboxy Analog |
1322062-57-6 |
95% |
| Y1239303 |
GADOXETATE DISODIUM |
135326-22-6 |
98% |
| Y1239388 |
Isosilybin A |
142796-21-2 |
99% |
| Y3147313 |
(2R,3R)-3,5,7-Trihydroxy-2-[(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzo[1,4]dioxin-6-yl]-4-chromanone |
142796-22-3 |
98% |
| Y3317648 |
lasiocarpine N-oxide |
127-30-0 |
98% |
| Y3307401 |
(R)-9-Hydroxy Risperidone |
130049-85-3 |
95% |
| Y3117918 |
N4-Benzoyl-7'-OH-N-trityl Morpholino cytosine |
125515-31-3 |
98% (contains ~10%solvents) |
| Y3310218 |
2'-Fluoro-2'-deoxy-N6-methylarabinoadenosine |
126502-12-3 |
95% |
| Y3117930 |
2,6-Diethoxypyridine |
13472-57-6 |
95% |
| Y3147776 |
Piperazine, 2-Methyl-1-(1-Methyl-4-piperidinyl) |
1267350-91-3 |
93% |
| Y3133890 |
Ethyl 1-Methyl-1H-1,2,3-triazole-5-carboxylate |
137156-35-5 |
94% |
| Y1047985 |
Benzylmethyl(pyrrolidin-3-ylmethyl)carbamate |
1245649-33-5 |
95% |
| Y1014459 |
ETHYL 5-PHENYL-3-ISOXAZOLECARBOXYLATE |
13599-24-1 |
97% |
| Y3296971 |
Piperazine-1,4-dicarboxylic acid benzyl ester tert-butyl ester |
121370-60-3 |
97% |
| Y3133933 |
Ethanone, 1-(2-bromophenyl)-2-fluoro- (9CI) |
135774-34-4 |
95% |
| Y3133930 |
Methyl 6-hydroxypyrazine-2-carboxylate |
13924-98-6 |
95% |
| Y1334824 |
6-BroMo-5-fluoropyridin-3-ol |
1211578-32-3 |
95% |
| Y1235056 |
(3-phenylisoxazol-5-yl)methylamine hydrochloride |
13608-55-4 |
95% |
| Y1257178 |
2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene |
123572-64-5 |
98% |
| Y3115565 |
2-Fluoro-3-iodo-4-Methylpyridine |
1214323-08-6 |
95% |
| Y3287640 |
(S)-tert-Butyl 2-(MethylcarbaMoyl)piperazine-1-carboxylate hydrochloride |
1217841-04-7 |
95% |
| Y3147609 |
2-aMino-2-(4-fluoro-3-(trifluoroMethyl)phenyl)ethanol hydrochloride |
1394820-12-2 |
95% |
| Y3313924 |
3-BROMO-5-IODO-2-METHYL BENZOIC ACID ETHYL ESTER |
1379317-96-0 |
96% |